069620 — Daewoong Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
KR₩1tn
Enterprise Value
KR₩2tn
Revenue
KR₩1tn

Annual balance sheet for Daewoong Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	129,831	177,120	173,734	140,651	137,685
Net Total Accounts Receivable
Net Total Receivables	205,787	147,652	159,635	179,243	177,954
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	526,256	528,351	520,401	548,968	574,824
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	391,708	393,690	395,866	440,890	521,919
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,245,668	1,366,908	1,410,687	1,563,341	1,770,311
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	262,080	326,750	460,660	472,831	667,117
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	726,354	815,914	841,156	955,323	1,003,008
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	519,315	550,994	569,531	608,017	767,303
Total Liabilities & Shareholders' Equity	1,245,668	1,366,908	1,410,687	1,563,341	1,770,311
Total Common Shares Outstanding